Key facts
- This page summarizes Jeffrey C. Lightcap's Form 4 filing for Heartflow, Inc. (HTFL).
- 12 reported transactions and 9 derivative rows are listed below.
- Accepted by SEC: 11 Aug 2025, 21:00.
Jeffrey C. Lightcap - 07 Aug 2025 Form 4 Insider Report for Heartflow, Inc. (HTFL)
- Reporting relationship
- Director
- Issuer ticker
- HTFL
- Reported as of
- 07 Aug 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 11 Aug 2025, 21:00:38 UTC
- Prior SEC filing
- 31 Mar 2023
- Next SEC filing
- 17 Dec 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Angela Ahmad, Attorney-in-Fact for Jeffrey C. Lightcap
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jeffrey C. Lightcap filed Form 4 for Heartflow, Inc. (HTFL) on 11 Aug 2025.
Change
- Previous filing in this sequence was filed on 31 Mar 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001519465
Primary reporting owner
Lightcap Jeffrey C
- Relationship
- Director
- Address
- C/O HEARTFLOW, INC., 331 E. EVELYN AVENUE, MOUNTAIN VIEW
- Signature
- /s/ Angela Ahmad, Attorney-in-Fact for Jeffrey C. Lightcap
- Signature date
- 11 Aug 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
HTFL
transaction
Common Stock
Conversion of derivative security
- Transaction value
- Shares
- +833,075
- Change %
- Price
- Shares after
- 833,075
- Date
- 11 Aug 2025
- Ownership
- By HealthCor Partners Fund II, L.P.
- Footnotes
- F1, F2, F3
HTFL
transaction
Common Stock
Conversion of derivative security
- Transaction value
- Shares
- +1,248,939
- Change %
- Price
- Shares after
- 1,248,939
- Date
- 11 Aug 2025
- Ownership
- By HealthCor Partners Fund, L.P.
- Footnotes
- F1, F3
HTFL
transaction
Common Stock
Conversion of derivative security
- Transaction value
- Shares
- +4,615,542
- Change %
- Price
- Shares after
- 4,615,542
- Date
- 11 Aug 2025
- Ownership
- By HCPCIV 1, LLC
- Footnotes
- F2, F3, F4, F5, F6
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
HTFL
transaction
Derivative
Series C Preferred Stock
Conversion of derivative security
- Transaction value
- Shares
- -624,471
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 11 Aug 2025
- Ownership
- By HealthCor Partners Fund II, L.P.
- Underlying class
- Common Stock
- Underlying amount
- 624,471
- Exercise price
- Footnotes
- F1, F3
HTFL
transaction
Derivative
Series C Preferred Stock
Conversion of derivative security
- Transaction value
- Shares
- -1,248,939
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 11 Aug 2025
- Ownership
- By HealthCor Partners Fund, L.P.
- Underlying class
- Common Stock
- Underlying amount
- 1,248,939
- Exercise price
- Footnotes
- F1, F3
HTFL
transaction
Derivative
Series D Preferred Stock
Conversion of derivative security
- Transaction value
- Shares
- -1,630,231
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 11 Aug 2025
- Ownership
- By HCPCIV 1, LLC
- Underlying class
- Common Stock
- Underlying amount
- 1,630,231
- Exercise price
- Footnotes
- F2, F3
HTFL
transaction
Derivative
Series D Preferred Stock
Conversion of derivative security
- Transaction value
- Shares
- -208,604
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 11 Aug 2025
- Ownership
- By HealthCor Partners Fund II, L.P.
- Underlying class
- Common Stock
- Underlying amount
- 208,604
- Exercise price
- Footnotes
- F2, F3
HTFL
transaction
Derivative
Series E Preferred Stock
Conversion of derivative security
- Transaction value
- Shares
- -1,099,378
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 11 Aug 2025
- Ownership
- By HCPCIV 1, LLC
- Underlying class
- Common Stock
- Underlying amount
- 1,099,378
- Exercise price
- Footnotes
- F3, F4
HTFL
transaction
Derivative
Series F Preferred Stock
Conversion of derivative security
- Transaction value
- Shares
- -1,337,337
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 11 Aug 2025
- Ownership
- By HCPCIV 1, LLC
- Underlying class
- Common Stock
- Underlying amount
- 1,337,337
- Exercise price
- Footnotes
- F3, F5
HTFL
transaction
Derivative
Series F-1 Preferred Stock
Conversion of derivative security
- Transaction value
- Shares
- -452,528
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 11 Aug 2025
- Ownership
- By HCPCIV 1, LLC
- Underlying class
- Common Stock
- Underlying amount
- 452,528
- Exercise price
- Footnotes
- F3, F5
HTFL
transaction
Derivative
Convertible Promissory Note
Conversion of derivative security
- Transaction value
- $0
- Shares
- -96,068
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 11 Aug 2025
- Ownership
- By HCPCIV 1, LLC
- Underlying class
- Common Stock
- Underlying amount
- 96,068
- Exercise price
- $15.20
- Footnotes
- F3, F6
HTFL
transaction
Derivative
Stock Option
Award
- Transaction value
- $0
- Shares
- +47,420
- Change %
- Price
- $0.000000
- Shares after
- 47,420
- Date
- 07 Aug 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 47,420
- Exercise price
- $19.00
- Footnotes
- F7
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 7 footnotes
Footnote F1
Each share of Series C preferred stock automatically converted into approximately 0.5764 shares of Heartflow, Inc.'s ("Heartflow") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis.
Footnote F2
Each share of Series D preferred stock automatically converted into approximately 0.6467 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis.
Footnote F3
Mr. Lightcap is a controlling member of each of HCPCIV 1, LLC, HealthCor Partners Fund II, L.P. and HealthCor Partners Fund, L.P. and may be deemed to have voting and dispositive power with respect to the shares. Mr. Lightcap disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Footnote F4
Each share of Series E preferred stock automatically converted into approximately 0.6951 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis.
Footnote F5
Each share of Series F preferred stock and Series F-1 preferred stock automatically converted into approximately 0.3425 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis.
Footnote F6
Upon the closing of Heartflow's initial public offering, the convertible promissory notes automatically converted into shares of Heartflow's common stock at a conversion price of 80% of the price per share in Heartflow's initial public offering, subject to a valuation ceiling of $2.0 billion. The shares of common stock that were issuable upon conversion of the convertible promissory note had no expiration date. These shares are reported in Table II above on an as-converted basis.
Footnote F7
The option will vest in full on the earlier of Heartflow's annual meeting of shareholders in 2026 and the first anniversary of the grant date, subject to continued service through such date.